(Q35167204)

6 August 2017

title

CG100649, a novel COX-2 inhibitor, inhibits colorectal adenoma and carcinoma growth in mouse models (English)

1 reference

6 August 2017

1 reference

Sun-Hee Kim

1

1 reference

6 August 2017

Ofer Margalit

2

1 reference

6 August 2017

Hiroshi Katoh

3

1 reference

6 August 2017

Dingzhi Wang

4

1 reference

6 August 2017

Hong Wu

5

1 reference

6 August 2017

Dianren Xia

6

1 reference

6 August 2017

Vijaykumar R Holla

7

1 reference

6 August 2017

Peiying Yang

8

1 reference

6 August 2017

Raymond N DuBois

9

1 reference

6 August 2017

language of work or name

1 reference

3 August 2014

1 reference

Investigational New Drugs

6 August 2017

published in

1 reference

6 August 2017

volume

32

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

1105-1112

1 reference

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

The role of anti-inflammatory drugs in colorectal cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

Prostaglandin E2 promotes intestinal tumor growth via DNA methylation

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

C-reactive protein and risk of colorectal adenoma according to celecoxib treatment

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

Hallmarks of Cancer: The Next Generation

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

13 July 2018

Eicosanoids and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

Emotion recollected in tranquility: lessons learned from the COX-2 saga.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

Aspirin use and survival after diagnosis of colorectal cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

The translational therapeutics of prostaglandin inhibition in atherothrombosis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

Celecoxib for the prevention of colorectal adenomatous polyps

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

Celecoxib for the prevention of sporadic colorectal adenomas

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

Localization of cyclooxygenase-2 in human sporadic colorectal adenomas

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

Expression of cyclooxygenase-1 and -2 in human colorectal cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356209

Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure

13 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10637-014-0144-Z

Quantitative high-performance liquid chromatography/electrospray ionization tandem mass spectrometric analysis of 2- and 3-series prostaglandins in cultured tumor cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10637-014-0144-Z

Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25085205

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25085205

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10637-014-0144-Z

1 reference

6 August 2017

1 reference

6 August 2017

1 reference